Jordi Barrachina

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Clinical Decision Support

Mitochondrial Dna

Ejection Fraction

Top Venues

Acta pharmaceutica (Zagreb, Croatia)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Muriel, Mónica Escorial, César Margarit, Jordi Barrachina, Cristian Carvajal, Domingo Morales, Ana María Peiró
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. Acta pharmaceutica (Zagreb, Croatia) 73 (2) (2023)
Pura Ballester, Cristina Espadas, Susana Almenara, Jordi Barrachina, Javier Muriel, Enrique Ramos, Natalia Toral, César Belda, Ana María Peiró
CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Jordi Barrachina, Cesar Margarit, Javier Muriel, Vicente López-Gil, Santiago López-Gil, Pura Ballester, Laura Mira-Lorente, Laura Agulló, Ana María Peiró
Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study. Biomedicines 10 (10) (2022)
Jordi Barrachina, César Margarit, Blanca Andreu, Thomas Zandonai, Pura Ballester, Javier Muriel, Esperanza Cutillas, Ana María Peiró
Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study. Acta pharmaceutica (Zagreb, Croatia) 72 (4) (2022)
Jordi Barrachina, César Margarit, Blanca Andreu, Thomas Zandonai, Pura Ballester, Javier Muriel, Esperanza Cutillas, Ana María Peiró
Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study. Acta pharmaceutica (Zagreb, Croatia) 72 (4) (2022)